Article info
PDFExtended essay
Research ethics and public trust in vaccines: the case of COVID-19 challenge trials
- Correspondence to Professor Nir Eyal, Center for Population-Level Bioethics, Dept of Philosophy (SAS) and Dept of HBSP (SPH), Rutgers University, New Brunswick, NJ 08901, USA; nir.eyal{at}rutgers.edu
Citation
Research ethics and public trust in vaccines: the case of COVID-19 challenge trials
Publication history
- Received December 13, 2021
- Accepted May 7, 2022
- First published May 20, 2022.
Article Versions
- Previous version (20 May 2022).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ. This article is made freely available for personal use in accordance with BMJ’s website terms and conditions for the duration of the covid-19 pandemic or until otherwise determined by BMJ. You may use, download and print the article for any lawful, non-commercial purpose (including text and data mining) provided that all copyright notices and trade marks are retained.https://bmj.com/coronavirus/usage